Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

Official Title

Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo

Brief Summary

Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo

Detailed Description

This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2
is different population subgroups in the State of São Paulo

Status

Unknown status

Conditions

COVID

SARS-CoV 2

Interventions

Diagnostic Test: Serological test

IgM and IgG for SARS-CoV-2

Diagnostic Test: Nasopharyngeal Swab

PCR for SARS-CoV-2

Diagnostic Test: Oropharyngeal Swab

PCR for SARS-CoV-2

Eligibility Criteria

Inclusion Criteria:

- All potential volunteers invited to participate in the study.

Exclusion Criteria:

- All potential eligible participants, but who do not show interest in participating in
the study.

Eligibility Gender

All

Eligibility Age

Minimum: 6 Months ~ Maximum: 100 Years

Contacts

Alexander R Precioso, MD, PhD
+55 11 3723-2121
alexander.precioso@butantan.gov.br

Investigators

Alexander R Precioso, MD, PhD, Study Chair
Instituto butantan

NCT Number

NCT04408014

MeSH Terms

Infections

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Butantan Institute

Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA